These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11244999)

  • 1. [p53 alterations in human lung cancer and their correlation with clinicopathological features and prognosis].
    Zhang J; Zheng J; Fang W
    Zhonghua Bing Li Xue Za Zhi; 1998 Aug; 27(4):286-9. PubMed ID: 11244999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation between p53 gene mutation and protein expression in 30 cases of human lung cancer].
    Zhang J; Zheng J; Fang W
    Zhonghua Yi Xue Za Zhi; 1998 Nov; 78(11):846-9. PubMed ID: 11038779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of the p53 protein accumulation and p53 gene mutation in squamous cell carcinoma of the lung].
    Li S; Liu H; Wang D
    Zhonghua Bing Li Xue Za Zhi; 1998 Apr; 27(2):123-6. PubMed ID: 11244963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
    Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
    Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis of lymph node micrometastases in human lung carcinoma: determination of p53 gene mutations by polymerase chain reaction-temperature gradient gel electrophoresis (PCR-TGGE)].
    Xu ML; Wu BQ; Zhong HH; Yang X; Heng WJ
    Ai Zheng; 2004 Jul; 23(7):794-8. PubMed ID: 15248914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases.
    Hashimoto T; Kobayashi Y; Ishikawa Y; Tsuchiya S; Okumura S; Nakagawa K; Tokuchi Y; Hayashi M; Nishida K; Hayashi S; Hayashi J; Tsuchiya E
    Cancer Res; 2000 Nov; 60(22):6472-8. PubMed ID: 11103815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The expression of Mdm2 protein and p53 mutation in lung squamous cell carcinomas and their clinicopathological significance].
    Zhang J; Liu H; Li S; Gu C
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Mar; 22(3):163-5. PubMed ID: 11812371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 gene mutations in non-small cell lung cancer detected by polymerase chain reaction single-strand conformation polymorphism analysis.
    Zhao Y; Wu D; Xiang X; Zhang B; Zhou N; Hu Y
    Chin Med Sci J; 1999 Sep; 14(3):134-7. PubMed ID: 12903811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
    Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Piattoni S; Di Carlo L; Semeraro A; Darwish S; Tofanetti FR; Stocchi L; Mihaylova Z; Bellezza G; Del Sordo R; Daddi G; Crinò L; Tonato M
    J Thorac Oncol; 2008 Apr; 3(4):365-73. PubMed ID: 18379354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
    Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleomorphic (giant and spindle cell) carcinoma is genetically distinct from adenocarcinoma and squamous cell carcinoma by K-ras-2 and p53 analysis.
    Przygodzki RM; Koss MN; Moran CA; Langer JC; Swalsky PA; Fishback N; Bakker A; Finkelstein SD
    Am J Clin Pathol; 1996 Oct; 106(4):487-92. PubMed ID: 8853037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.
    Hashimoto T; Tokuchi Y; Hayashi M; Kobayashi Y; Nishida K; Hayashi S; Ishikawa Y; Tsuchiya S; Nakagawa K; Hayashi J; Tsuchiya E
    Cancer Res; 1999 Nov; 59(21):5572-7. PubMed ID: 10554037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exon 8 mutation of p53 gene associated with nodal metastasis in non-small-cell lung cancer.
    Lee LN; Shew JY; Sheu JC; Lee YC; Lee WC; Fang MT; Chang HF; Yu CJ; Yang PC; Luh KT
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1667-71. PubMed ID: 7952630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation.
    Winter SF; Minna JD; Johnson BE; Takahashi T; Gazdar AF; Carbone DP
    Cancer Res; 1992 Aug; 52(15):4168-74. PubMed ID: 1322237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 in surgically treated and pathologically staged cervical cancer: correlation with local tumor progression, but not with lymphatic spread.
    Horn LC; Fischer U; Hänel C; Kuhn H; Raptis G; Bilek K
    Pathol Res Pract; 2001; 197(9):605-9. PubMed ID: 11569924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological significance of nuclear accumulation of tumor suppressor gene p53 product in primary lung cancer.
    Hiyoshi H; Matsuno Y; Kato H; Shimosato Y; Hirohashi S
    Jpn J Cancer Res; 1992 Jan; 83(1):101-6. PubMed ID: 1544866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptotic regulators: P53 and survivin expression in non-small cell lung cancer.
    Porebska I; Sobańska E; Kosacka M; Jankowska R
    Cancer Genomics Proteomics; 2010; 7(6):331-5. PubMed ID: 21156966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
    Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
    Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on genes associated with biologic behavior in human lung cancer].
    Bai L; Sun Y; Li S
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan; 21(1):23-5. PubMed ID: 11263295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.